Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Cloud-based bioinformatics platform for genomics-based precision medicine

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOSG20200519001
Publicado:
27/05/2020
Caducidad:
28/05/2021
Resumen:
A Singapore software consultancy and bioinformatics service provider has developed a cloud-based platform for healthcare and agriculture applications to manage, analyse and visualise the voluminous ´omics´ data through the use of sequencing technologies, cutting edge bioinformatics solutions, data management and analysis. The company seeks to partner SMEs from France/EUREKA Network in research/technical cooperation with an interest to jointly participate in bi-lateral funding programs.

Details

Tittle:
Cloud-based bioinformatics platform for genomics-based precision medicine
Summary:
A Singapore software consultancy and bioinformatics service provider has developed a cloud-based platform for healthcare and agriculture applications to manage, analyse and visualise the voluminous ´omics´ data through the use of sequencing technologies, cutting edge bioinformatics solutions, data management and analysis.

The company seeks to partner SMEs from France/EUREKA Network in research/technical cooperation with an interest to jointly participate in bi-lateral funding programs.
Description:
The evolution of Next-Generation Sequencing (NGS) technologies has reshaped genomics research and substantially reduced the cost of sequencing ´omics´ data. However, the challenge faced by many researchers is to manage, analyse and visualise the vast and rapidly growing volume and depth of the data, as most clinical genomics service providers prioritise sequencing data generation over data analysis.

The Singapore SME has developed a cloud-based, interactive digital platform that can be used by researchers of genomics-based precision medicine to analyse big data with greater accuracy and speed through effective utilisation of supercomputing power. Highly scalable, the platform can scale from tens of cores to thousands of cores, and can take just 48 hours to visualise genomic variants from human exome sequencing.

Designed to allow the integration of any number of algorithms in a well structured and distributed environment, the key component in this platform is the workflows that are automated, dynamic and fully transparent to the end user. This is in contrast to black box vertical modules provided by some service providers.

The company has two distinct platforms for healthcare and agriculture applications. These automated NGS workflows are able to accelerate personalised healthcare with options for:

· Genome sequence assembly and annotation
· Novel variant detection
· Exome analysis
· Any custom workflow

The automated data-¿ow and simultaneous analysis, once the critical parameters are set, alleviates error-prone manual analysis and increases accuracy and ef¿ciency in terms of man-power utilisation. The analysed datasets can be automatically exported to a cloud-based knowledge base that have customised user interfaces, which allow end users to better interact with the data.

The Singapore SME is keen to partner SMEs from France or participating EUREKA countries to jointly collaborate in a project under the following types of agreement:

1) Research cooperation - Both companies will cooperate to co-develop new products or services to be introduced to the market.

2) Technical cooperation - Resources
are pooled and skills are shared between both parties in the development of the technical aspects of a product or technology.
Advantages and Innovations:
This platform offers a complete value chain in genomics-based precision medicine that includes sample collection, sequencing, data analysis, custom report generation and custom knowledge base setup in the cloud.

Advantages and innovations of the solution include:

· Rapid implementation of various sequence related projects
· Choose from wide repository of pre-configured packages of sequencing technologies and data analysis pipelines or opt for a customised solution
· Access to rapidly evolving sequence technologies and latest algorithms for sequence assembly, annotation and analysis
· Highly accurate and transparent data analytics that can be quickly customised to meet speci¿c requirements such as ethnicity, somatic variants etc.
· Does away with the need to set up an expensive sequencing laboratory with supporting bioinformatics or equipment maintenance/personnel training
· Option to choose the most suitable sequencing technology for each project, without being tied down to a particular sequencing technology
· Secure, transparent and confidential. Highly secure and transparent with utmost confidentiality. No conflict of interest at any level.
· Track project progress via the Internet through robust XML and Java/J2EE data management environment
· Cloud-based customisable workflows for sequence assembly, annotation and analysis that use the latest and most relevant algorithms for the project (patented workflows for life sciences).
· User friendly interface based on Web 2.0 technology/.NET technology
· All processes are compliant with international standards
Stage of Development:
Field tested/evaluated
IPs:
Patent(s) applied for but not yet granted
CommeR Statunts Regarding IPR Status:
Patents pending for UK and EU.

Partner sought

Type and Role of Partner Sought:
The Singapore company is keen to establish research or technical cooperation with SMEs of any size from France or participating EUREKA countries to jointly participate in bi-lateral funding programs.

In view of the current CoVid situation, the company is especially keen to partner with those interested to leverage on its platform to study the SARS-CoV-2 (e.,g., metagenomics, gene expression, etc) to work towards a vaccine or treatment.

Type of project partners include:
· Pharmaceutical companies / research institutes
· Life Science companies / research institutes
· Agriculture companies / plant or crop research institutes

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English

Keywords

Technology Keywords:
06003001 Bioinformática
01003010 Databases, Database Management, Data Mining
01003015 Gestión de conocimiento, gestión de procesos
06001012 Investigaciones médicas
01003024 Tecnologías de la nube